(Q38125412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

parkinsonian syndrome

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Satya Prakash Gupta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sharawan Yadav

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Naveen Kumar Singhal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Manindra Nath Tiwari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Mahendra Pratap Singh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

31 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

262-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900742%20AND%20SRC:MED&resulttype=core&format=json

Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

The discovery of nitric oxide and its role in vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Nitric oxide synthase regulation and diversity: implications in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Binding sites of nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Distinct dimer interaction and regulation in nitric-oxide synthase types I, II, and III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

DHR domains in syntrophins, neuronal NO synthases and other intracellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Nitric oxide synthases in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Plasma membrane calcium ATPase 4b inhibits nitric oxide generation through calcium-induced dynamic interaction with neuronal nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Nitric oxide and S-nitrosylation: excitotoxic and cell signaling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

NO-cGMP signaling and regenerative medicine involving stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Relationship of nitric oxide synthase induction to peroxynitrite-mediated oxidative damage during the first week after experimental traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

The nitric oxide-cyclic GMP pathway regulates FoxO and alters dopaminergic neuron survival in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Nitric oxide synthesis and cGMP production is important for neurite growth and synapse remodeling after axotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Involvement of multiple protein kinases in cPLA2 phosphorylation, arachidonic acid release, and cell death in in vivo and in vitro models of 1-methyl-4-phenylpyridinium-induced parkinsonism--the possible key role of PKG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Does nitric oxide modulate mitochondrial energy generation and apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Overexpressed neuroglobin raises threshold for nitric oxide-induced impairment of mitochondrial respiratory activities and stress signaling in primary cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Nitric oxide and mitochondrial signaling: from physiology to pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Role of oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Redox Regulation of Protein Function via Cysteine S-Nitrosylation and Its Relevance to Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Hypothermia reduces toll-like receptor 3-activated microglial interferon-β and nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Common polymorphisms in nitric oxide synthase (NOS) genes influence quality of aging and longevity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Comprehensive association analysis of the NOS2A gene with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

5'-flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

NOS2A and the modulating effect of cigarette smoking in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Nitric oxide mediates iron release from ferritin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Thiamine and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Animal models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

JNK activation by tetrahydrobiopterin: implication for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

S-Nitrosylation of Critical Protein Thiols Mediates Protein Misfolding and Mitochondrial Dysfunction in Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Neuroprotection by pharmacologic blockade of the GAPDH death cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study .

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

7-Nitroindazole down-regulates dopamine/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Oxidative and inflammatory pathways in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Mechanism for generation of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Role of nitric oxide in rotenone-induced nigro-striatal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Nitrosative stress-induced Parkinsonian Lewy-like aggregates prevented through polyphenolic phytochemical analog intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

A highly reproducible rotenone model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Catalpol attenuates nitric oxide increase via ERK signaling pathways induced by rotenone in mesencephalic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Interferon-γ plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

The involvement of nitric oxide in maneb- and paraquat-induced oxidative stress in rat polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Anti-inflammatory effect of ginsenoside Rg5 in lipopolysaccharide-stimulated BV2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Effects of cyclooxygenase inhibitor pretreatment on nitric oxide production, nNOS and iNOS expression in rat cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Striatal neuroinflammation promotes Parkinsonism in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

A guide to neurotoxic animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Free radical production induced by methamphetamine in rat striatal synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

21 January 2018

12 December 2020

Nitric oxide modulates dopaminergic regulation of prepulse inhibition in the basolateral amygdala.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Different effects of 7-nitroindazole in reserpine-induced hypolocomotion in two strains of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

A model of nitric oxide induced α-synuclein misfolding in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Expression of mutant alpha-synuclein modulates microglial phenotype in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

LRRK2 and autophagy: a common pathway for disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

The effect of nNOS inhibitors on toxin-induced cell death in dopaminergic cell lines depends on the extent of enzyme expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Role of nitric oxide in motor control: implications for Parkinson's disease pathophysiology and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/deltaFosB expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Melatonin synthetic analogs as nitric oxide synthase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Parkinson's disease mouse models in translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Protective effect of theaflavins on neuron against 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8517-4

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

21 January 2018

1 reference

12 December 2020

Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis

1 reference

12 December 2020

Effect of phosphorylated-ERK1/2 on inducible nitric oxide synthase expression in the substantia nigra of mice with MPTP-induced Parkinson disease

1 reference

12 December 2020

No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes

1 reference

12 December 2020

Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease

1 reference

12 December 2020

Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse

1 reference

12 December 2020

[Nitric oxide synthase, typical flavohemoproteins and their complicated enzymology]

1 reference

12 December 2020

Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo

1 reference

12 December 2020

Limitations of animal models of Parkinson's disease

1 reference

12 December 2020

Role of nitric oxide in growth of solid tumours: a balancing act.

1 reference

12 December 2020

Nitric oxide-containing neurons in long-term grafts in a rat model of Parkinson's disease

1 reference

12 December 2020

Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies.

1 reference

12 December 2020

Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.

1 reference

12 December 2020